Cancer Vaccines Market Share

Statistics for the 2023 & 2024 Cancer Vaccines market share, created by Mordor Intelligence™ Industry Reports. Cancer Vaccines share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Cancer Vaccines Industry

The cancer vaccine market is consolidated and consists of a few major players. Market players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, mergers, and acquisitions. Companies, like AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline, Roche, and Merck & Co. Inc., OSE Immunotherapeutics, Sanofi, and Moderna, among others, hold substantial shares in the cancer vaccine market.

Cancer Vaccines Market Leaders

  1. OSE Immunotherapeutics

  2. GlaxoSmithKline PLC

  3. F Hoffmann-La Roche AG (Genentech)

  4. Moderna Inc.

  5. Merck & Co. Inc.

*Disclaimer: Major Players sorted in no particular order

cancer vaccines- MC.jpg

Cancer Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)